<DOC>
	<DOCNO>NCT01542268</DOCNO>
	<brief_summary>The purpose study determine therapeutic effectiveness oral pentoxifylline treatment patient IBS .</brief_summary>
	<brief_title>Effect Pentoxifylline Tight Junctions ( TJs ) Intestinal Mucosa Patients With Irritable Bowel Syndrome ( IBS )</brief_title>
	<detailed_description>Disruption intestinal epithelial barrier part pathophysiology IBS favor immune activation present mucosa patient development symptom IBS . To evaluate effect treatment pentoxifylline ( PTX ) patient IBS relate clinical response modulation component epithelial barrier level intestinal mucosa .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>Age 18 65 year old Most patient IBS chose patient go Digestive System ambulatory external medical office Center . Be studied clinical monitoring al least 6 month include . Fulfill Roma III Criteria IBS ( Gastroenterology 2006 ; 130:137790 ) moderatesevere seriousness accord Modification Francis Scale 2 week colon biopsia , patient cann´t take salicylate , NSAID , antibiotic , anticholinergic , opiates medication / product asintomatic treatment diarrea . 3 month colon biopsia , patient cann´t take medicament corticoides , antihistamine immunosuppressive 6 month colon biopsia , patient cann´t recive radiotherapy chemotherapy . Pentoxifilina Alergic Reactions Pregnants Grave kidney failure Grave Hepatic failure Menthal legal disability sign consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>pentoxifylline</keyword>
	<keyword>tight junction signal</keyword>
	<keyword>intestinal epithelial barrier</keyword>
	<keyword>irritable bowel syndrome</keyword>
</DOC>